We studied 22 men with prolactin-secreting pituitary tumors and hypogonadism. Twenty complained of impotence, nine had visual impairment, and three experienced galactorrhea. None of the 17 patients undergoing operation or radiotherapy, or both, were subsequently normoprolactinemic. In all 13 patients treated with bromocryptine major clinical improvement was associated with a decrease in serum prolactin levels and in nine with an increase in serum testosterone. Two patients receiving testosterone replacement therapy showed improved potency only after bromocryptine was administered. The results indicate that hyperprolactinemia frequently induces hypogonadism in men, that bromocryptine ameliorates symptoms of disease previously unchanged by operation or radiotherapy, and that the impotence observed may not be solely the result of hypogonadism.
This article has been cited by other articles:
LeBaron, M. J., Ahonen, T. J., Nevalainen, M. T., Rui, H.
(2007). In Vivo Response-Based Identification of Direct Hormone Target Cell Populations Using High-Density Tissue Arrays. Endocrinology
148: 989-1008
[Abstract][Full Text]
Gillam, M. P., Molitch, M. E., Lombardi, G., Colao, A.
(2006). Advances in the Treatment of Prolactinomas. Endocr. Rev.
27: 485-534
[Abstract][Full Text]
De Rosa, M., Zarrilli, S., Vitale, G., Di Somma, C., Orio, F., Tauchmanova', L., Lombardi, G., Colao, A.
(2004). Six Months of Treatment with Cabergoline Restores Sexual Potency in Hyperprolactinemic Males: An Open Longitudinal Study Monitoring Nocturnal Penile Tumescence. J. Clin. Endocrinol. Metab.
89: 621-625
[Abstract][Full Text]
Schlechte, J. A.
(2003). Prolactinoma. NEJM
349: 2035-2041
[Full Text]
Gillam, M. P., Middler, S., Freed, D. J., Molitch, M. E.
(2002). The Novel Use of Very High Doses of Cabergoline and a Combination of Testosterone and an Aromatase Inhibitor in the Treatment of a Giant Prolactinoma. J. Clin. Endocrinol. Metab.
87: 4447-4451
[Abstract][Full Text]
Colao, A., De Rosa, M., Pivonello, R., Balestrieri, A., Cappabianca, P., Di Sarno, A., Rochira, V., Carani, C., Lombardi, G.
(2002). Short-Term Suppression of GH and IGF-I Levels Improves Gonadal Function and Sperm Parameters in Men with Acromegaly. J. Clin. Endocrinol. Metab.
87: 4193-4197
[Abstract][Full Text]
Tansey, M J, Schlechte, J A
(2001). Pituitary production of prolactin and prolactin-suppressing drugs. Lupus
10: 660-664
[Abstract]
Kandeel, F. R., Koussa, V. K. T., Swerdloff, R. S.
(2001). Male Sexual Function and Its Disorders: Physiology, Pathophysiology, Clinical Investigation, and Treatment. Endocr. Rev.
22: 342-388
[Abstract][Full Text]
Pinzone, J. J., Katznelson, L., Danila, D. C., Pauler, D. K., Miller, C. S., Klibanski, A.
(2000). Primary Medical Therapy of Micro- and Macroprolactinomas in Men. J. Clin. Endocrinol. Metab.
85: 3053-3057
[Abstract][Full Text]
Hayes, F. J., Eichhorn, J. H.
(2000). Case 12-2000- A 60-Year-Old Man with Persistent Gynecomastia after Excision of a Pituitary Adenoma. NEJM
342: 1196-1204
[Full Text]
Krieger, D., Liotta, A.
(1979). Pituitary hormones in brain: where, how, and why?. Science
205: 366-372
[Abstract]
Previous
